Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.91

€1.91

1.600%
0.03
1.600%
-

-

 
12.01.26 / Frankfurt WKN: A3CRZT / Name: Affluent Medical Sas / Stock / ? /

Affluent Medical Sas Stock

There is an upward development for Affluent Medical Sas compared to yesterday, with an increase of €0.030 (1.600%).

Pros and Cons of Affluent Medical Sas in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
Affluent Medical : Promising results for the Epygon biomimetic mitral valve presented at the TCT cardiology congress in the United States.
Affluent Medical : Promising results for the Epygon biomimetic mitral valve presented at the TCT cardiology congress in the United States.
Affluent Medical : Promising results for the Epygon biomimetic mitral valve presented at the TCT cardiology congress in the United States.
Affluent Medical: H1 2025 RESULTS: Affluent Medical took major new and transformative steps during the first half of 2025
Affluent Medical: H1 2025 RESULTS: Affluent Medical took major new and transformative steps during the first half of 2025
Affluent Medical: H1 2025 RESULTS: Affluent Medical took major new and transformative steps during the first half of 2025